Private Label Tranexamic Acid SPF 50 Body Milk Low MOQ

The minimum order quantity for a private label tranexamic acid SPF 50 body milk typically starts at 500 units with specialist cosmetic contract manufacturers who cater to indie and emerging brands, and rises to 1,000–2,000 units at mid-scale facilities that balance flexibility with production efficiency. Large-scale manufacturers focused on retail and export accounts usually set MOQs at 5,000–10,000 units or higher. Several variables pull the MOQ floor upward. First, SPF 50 products for the US market must be made in an FDA-registered OTC drug facility. These facilities operate under stricter cGMP standards and have higher overhead than cosmetic-only manufacturers, which is reflected in their minimum run sizes — often 1,000–2,000 units minimum even for the most indie-friendly operations. Second, the active ingredient concentration matters. If you need tranexamic acid at 3–5% rather than using a stock SPF 50 base with a low add-in, the manufacturer may need to run additional stability testing before committing to a small batch. Some manufacturers price this as a development fee and then allow a lower MOQ; others simply set a higher MOQ to amortise the testing cost across enough units. Third, packaging format drives MOQ independently of the formula. Custom-moulded bottles or tubes may carry a tooling minimum of 5,000–10,000 units from the packaging supplier, even if the fill manufacturer can run 500. Using stock packaging shapes (available in most manufacturers' warehouses) is the most effective way to keep MOQ genuinely low at early stage. For EU-market launches, where sunscreens are regulated as cosmetics rather than OTC drugs, you have access to a wider pool of ISO 22716-certified manufacturers, and MOQs as low as 300–500 units are achievable, particularly from manufacturers in Italy, South Korea, and the UK who specialise in boutique runs. A common mistake founders make is negotiating MOQ without nailing down what is included in that number — specifically whether SPF testing, stability testing, and label printing are inside the MOQ cost or billed separately. Always get an itemised quote. The AJ Cosmo Labs app lets you post a brief specifying your target MOQ and automatically surfaces manufacturers who have confirmed they can meet it, saving weeks of back-and-forth with suppliers who are not a match.

The fully landed cost of a private label tranexamic acid SPF 50 body milk has several layers, and the cost per unit visible on a manufacturer's quote sheet rarely reflects what you will actually spend to get finished, retail-ready product into your hands. Formulation and development fees are the first line item. If you are using the manufacturer's existing SPF 50 stock base and adding tranexamic acid, development fees are typically $500–$2,500. If you are commissioning a custom formula from scratch — specific UV filter blend, custom texture, fragrance, additional actives — development can run $3,000–$8,000 and take 8–14 weeks before you even begin stability testing. SPF testing is a mandatory separate cost that many first-time founders do not budget for. In-vivo SPF 50 testing (required for the US FDA monograph) costs $3,500–$6,000 per formula through an accredited lab, with a turnaround of 8–12 weeks. EU-compliant in-vitro testing under ISO 24444 is cheaper at $1,500–$3,000. Broad-spectrum testing (critical angle or wavelength) is an additional $500–$1,500. If your formula fails its first SPF test, reformulation and retesting adds cost and time. Stability testing costs $800–$2,500 depending on the number of conditions (accelerated, real-time, freeze-thaw) and is required for regulatory compliance in virtually every major market. On a per-unit basis at a 1,000-unit run, expect $8–$14 per unit including formula, packaging (stock pump bottle, label), fill, and standard quality checks. At 5,000 units, the same formula drops to roughly $4–$7 per unit. At 10,000+ units, experienced manufacturers can reach $2.50–$4.50 depending on complexity. Additional costs to plan for: label design ($500–$2,000), regulatory review and CPSR for EU markets ($1,500–$4,000), freight, import duties, and warehouse/3PL fees. The most expensive mistake founders make at this stage is under-budgeting for SPF testing and then running out of capital before the product is legally sellable. Build testing costs into your launch budget from day one. AJ Cosmo Labs surfaces manufacturers who are transparent about all-in costs when you post your brief, so you can compare total project cost rather than just per-unit manufacturing price.

The realistic end-to-end timeline from first supplier conversation to finished goods in your warehouse ranges from 14 to 28 weeks, depending on how much custom development is required and which regulatory market you are targeting. Weeks 1–2: Supplier selection and brief. You identify a capable contract manufacturer, sign an NDA, share your brief (target SPF, TXA concentration, texture, target market, packaging), and receive a proposal and development agreement. Weeks 2–8: Formula development. Using a stock SPF 50 base with TXA added is the fastest path and can be done in 2–4 weeks. A fully custom formula with a new UV filter combination, additional actives, and specific texture profile takes 6–12 weeks and usually involves 2–3 lab iterations before you approve a formula sample. Weeks 6–18: Stability and SPF testing. These run partially in parallel with late-stage development. Accelerated stability testing (40°C/75% RH for 3 months) begins as soon as a stable formula sample is confirmed. In-vivo SPF testing in an accredited lab takes 8–12 weeks from sample submission. If the formula fails SPF testing, add 4–8 weeks for reformulation and retest. This is the single biggest wildcard in your timeline. Weeks 16–22: Regulatory and label approval. FDA OTC Drug Facts panel review, EU CPSR sign-off, or Health Canada product licence (if applicable) must be completed before manufacturing begins. Allow 4–8 weeks for regulatory review depending on the market. Weeks 20–28: Bulk manufacturing, filling, and quality release. A production run of 1,000–5,000 units typically takes 2–4 weeks of active manufacturing. Quality control testing (microbial, pH, viscosity, appearance) adds 1–2 weeks before goods are released. The fastest realistic scenario — a founder using a manufacturer's proven stock SPF 50 base, adding TXA, targeting the EU only, and using stock packaging — is around 14–16 weeks. A US-market launch with custom formulation and full in-vivo SPF testing is realistically 22–28 weeks for a first-time project. AJ Cosmo Labs connects you with manufacturers who have pre-validated SPF 50 bases ready to go, which is the single highest-leverage way to compress your timeline. Browse the iOS app to find manufacturers who list existing SPF 50 body emulsion formulas in their capability profiles.

Tranexamic acid (TXA) in cosmetic body formulations is most commonly used at 2–5% by weight, with the concentration choice driven by positioning, cost, and stability considerations rather than safety limits — TXA has an excellent tolerability profile at these levels and is not restricted in EU or US cosmetics regulations. At 2%, tranexamic acid delivers a meaningful brightening and melanin-inhibiting effect that clinical literature supports for skin tone-evening. This is the most common concentration in mass-market and mid-range body brightening products. It is the easiest level to stabilise in an SPF emulsion because TXA's pH requirements (it is most stable at pH 5.5–7.0) align reasonably well with typical sunscreen formulas. At 3–5%, you enter premium and clinical-positioning territory. Brands use concentrations in this range to justify higher retail price points and to differentiate in a competitive brightening market. However, at 5%, TXA can start to interact with certain chemical UV filters and may affect emulsion viscosity, so manufacturers with specific experience at this level are important — not every formulator who has used 2% TXA has validated a 5% TXA SPF emulsion. Transparency note: while TXA in cosmetics is distinct from its pharmaceutical use as a hemostatic agent (where doses are orders of magnitude higher), some consumers research the ingredient. Having clear, benefit-focused copy about its melanogenesis-inhibiting mechanism (blocking plasmin-mediated activation of melanocytes) supports consumer confidence. For body application specifically — where you are covering a larger surface area than the face — many cosmetic chemists position 2–3% as the sweet spot: efficacious, cost-efficient at scale, and stable across a wider range of production conditions. If you want to make a 5% TXA claim, confirm with your manufacturer that they have stability data at that level specifically in an SPF 50 emulsion, not just in a plain lotion base. Other actives that pair well with TXA in this type of formula include niacinamide (3–5%, synergistic pigment reduction), kojic acid dipalmitate (0.5–1%), and alpha-arbutin (0.5–2%). Each addition increases development and stability testing scope. AJ Cosmo Labs can connect you with experienced cosmetic chemists through the iOS app who can advise on the right combination for your specific brief.

Yes — in the United States, any leave-on product with an SPF claim is classified as an OTC (over-the-counter) drug by the FDA, regardless of whether it also has cosmetic properties like moisturising or brightening. This applies to your tranexamic acid SPF 50 body milk. You do not need pre-market approval in the traditional sense, but you must comply with the OTC drug monograph system, and the requirements are substantially more demanding than for a plain cosmetic. First, the UV filters in your formula must appear on the FDA's approved OTC sunscreen monograph list. Filters approved for US use include avobenzone (up to 3%), octocrylene (up to 10%), octisalate (up to 5%), homosalate (up to 15%), oxybenzone (up to 6%), titanium dioxide (up to 25%), and zinc oxide (up to 25%). UV filters widely used in Europe and Asia — such as Tinosorb S, Tinosorb M, and Mexoryl XL — are NOT currently approved under the US monograph, meaning formulas built around these filters cannot be legally sold as sunscreens in the US without going through a New Drug Application (NDA), a multi-year, multi-million dollar process. Second, manufacturing must occur in an FDA-registered OTC drug facility operating under 21 CFR Part 211 (pharmaceutical GMP), not merely ISO 22716 (cosmetic GMP). This is a critical distinction that disqualifies the majority of cosmetic contract manufacturers from producing SPF products for the US market. Third, your product label must include a Drug Facts panel in the specific FDA-mandated format: active ingredients listed with their UV filter percentages, "Uses" (protects against sunburn), "Warnings" (including the skin cancer/skin aging alert), "Directions" (apply 15 minutes before sun exposure, reapply after 80 minutes of swimming/sweating), and "Inactive Ingredients" listed alphabetically. Fourth, an in-vivo SPF test conducted according to the FDA's 2011 final rule protocol is required to substantiate your SPF 50 claim. In-vitro data alone is not sufficient for US market claims. The tranexamic acid component has no specific FDA OTC drug classification; it is treated as a cosmetic inactive ingredient in this context. It does not require separate approval. For founders new to the US sunscreen regulatory pathway, working with a manufacturer who already holds FDA OTC drug facility registration and has produced compliant SPF products is non-negotiable. AJ Cosmo Labs screens manufacturing partners for regulatory credentials — download the iOS app and filter for FDA OTC-registered facilities when posting your brief.

Finding a contract manufacturer who is simultaneously capable of SPF 50 formulation, has experience with tranexamic acid, holds the right regulatory certifications, and accepts a low MOQ is genuinely difficult because these four criteria together eliminate most of the market. Here is the practical approach that works. Start with capability, not price. Your first filter should be SPF manufacturing experience. Ask any prospective manufacturer: do you have a validated SPF 50 body emulsion in your existing formula library, and can you share the SPF test certificate? A manufacturer who can show you a tested SPF 50 base they already produce has de-risked the hardest part of your project. A manufacturer who has never made SPF 50 is going to charge you for a full development cycle and you carry the risk of failed testing. Second filter: regulatory fit for your target market. For the US, the manufacturer must hold FDA OTC drug facility registration — verifiable at accessdata.fda.gov by searching their facility name or DUNS number. For EU, ISO 22716 certification is baseline; ask if they can provide or recommend a Responsible Person service. For both markets, ask whether they have previously produced products that successfully passed SPF testing for that specific regulatory pathway. Third filter: MOQ compatibility. Many capable SPF manufacturers have minimum runs of 5,000–10,000 units because their production lines are set up for commercial-scale clients. Indie-friendly manufacturers exist — particularly in South Korea, Italy, and the UK for EU-market products, and in the US for FDA OTC-compliant production — but you have to seek them out specifically. Ask directly: what is your absolute minimum fill run for a body lotion in a stock pump bottle? Fourth filter: tranexamic acid experience. Ask specifically whether they have formulated with TXA at 2% or above in an emulsion that also contains UV filters, and whether they have stability data on such a formula. Many formulators have used TXA in serums or face creams but not in SPF emulsions, where the interaction between TXA and UV filters at the required pH adds complexity. Trade directories and Google cold outreach are slow and unreliable for finding this specific combination of capabilities. You will contact dozens of manufacturers before finding ones who actually meet all four criteria. AJ Cosmo Labs is designed to solve exactly this problem: the iOS app lists vetted cosmetic contract manufacturers with their capabilities, regulatory certifications, and MOQs disclosed upfront. Post a brief describing your tranexamic acid SPF 50 body milk, your target market, and your MOQ requirement, and the platform surfaces manufacturers who are a genuine match — cutting weeks off your sourcing timeline. Download the app from the App Store to get started.

Packaging selection for an SPF 50 body milk with tranexamic acid is a functional decision as much as a branding one. The active ingredient and sunscreen formulation impose constraints that a plain lotion does not. Airless pump bottles are the gold standard for formulas containing tranexamic acid, because TXA and some UV filters can oxidise on repeated air contact over the product's shelf life. An airless pump dispenses product without drawing air back into the container, preserving the integrity of the formula to the last dose. Sizes commonly used for body milk are 150ml, 200ml, and 250ml. The trade-off is cost: airless pumps run $0.60–$1.50 per unit more than standard pumps at low MOQ. Standard pump bottles (200–300ml, HDPE or PET) are the most cost-efficient option and work well when the formula contains sufficient antioxidant preservation (vitamin E, rosemary extract) to manage minor oxidation. Most body milks on shelf use this format. Choose opaque or UV-blocking PET if TXA oxidation is a concern. Tubes (100ml–200ml, aluminium or plastic laminate) are popular for travel-size and retail shelf formats, particularly in Asian markets where tube body milks are a familiar form factor. Aluminium tubes provide excellent barrier properties for UV filters and TXA. Plastic laminate tubes (like those used for toothpaste) are cheaper but require an internal lacquer lining to prevent UV filter degradation. Sachets (5–10ml single-dose) are useful for sample programmes and subscription box placements, and can be produced at low cost even at small quantities. They are not suitable as a primary retail format for SPF body milk but are an excellent sampling vehicle. From a regulatory standpoint, your packaging must accommodate the required label content — for the US, a Drug Facts panel with mandatory font sizes and layout takes up significant real estate, so bottles under 100ml become difficult to label compliantly. Design your label around the regulatory requirements of your target market before finalising packaging dimensions. Using stock packaging from your manufacturer's existing inventory is the most effective way to keep MOQ low and lead time short. Most indie-friendly manufacturers stock 150–250ml pump bottles in several colours and shapes. Custom-moulded packaging requires a tooling investment of $3,000–$15,000 and typically has its own 5,000–10,000 unit minimum from the packaging supplier, independent of your fill MOQ. AJ Cosmo Labs manufacturers list the packaging formats they stock and can fill, so you can match your formula brief to a manufacturer whose available packaging already fits your brand vision — browse the iOS app before locking in your packaging specification.